{"id":19247,"date":"2025-08-25T20:19:32","date_gmt":"2025-08-25T23:19:32","guid":{"rendered":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/"},"modified":"2025-08-25T20:19:32","modified_gmt":"2025-08-25T23:19:32","slug":"ascent-gyn-01-cancer-de-endometrio-recidivante-persistente","status":"publish","type":"ensaio_clinico","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/","title":{"rendered":"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente"},"content":{"rendered":"<div data-olk-copy-source=\"MessageBody\">Estudo de Sacituzumabe Govitecana versus tratamento de escolha do m\u00e9dico em participantes com c\u00e2ncer de endom\u00e9trio ap\u00f3s quimioterapia \u00e0 base de platina e imunoterapia<\/div>\n<div><b>&nbsp;<\/b><\/div>\n<div><b>Popula\u00e7\u00e3o:<\/b><\/div>\n<ul>\n<li>Evid\u00eancia documentada de c\u00e2ncer endometrial recidivante\/persistente (carcinoma endometrial ou carcinossarcoma);<\/li>\n<li>At\u00e9 3 linhas anteriores de terapia sist\u00eamica para c\u00e2ncer endometrial, incluindo quimioterapia sist\u00eamica \u00e0 base de platina e terapia anti-PD-1\/PD-L1, em combina\u00e7\u00e3o ou separadamente;<\/li>\n<li>&nbsp;ECOG 0 a 1.<\/li>\n<\/ul>\n<p><span data-olk-copy-source=\"MessageBody\">ClinicalTrials.gov: NCT06486441<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Estudo de Sacituzumabe Govitecana versus tratamento de escolha do m\u00e9dico em participantes com c\u00e2ncer de endom\u00e9trio ap\u00f3s quimioterapia \u00e0 base de platina e imunoterapia &nbsp; Popula\u00e7\u00e3o: Evid\u00eancia documentada de c\u00e2ncer endometrial recidivante\/persistente (carcinoma endometrial ou carcinossarcoma); At\u00e9 3 linhas anteriores de terapia sist\u00eamica para c\u00e2ncer endometrial, incluindo quimioterapia sist\u00eamica \u00e0 base de platina e terapia [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-19247","ensaio_clinico","type-ensaio_clinico","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino<\/title>\n<link rel=\"canonical\" href=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta property=\"og:description\" content=\"Estudo de Sacituzumabe Govitecana versus tratamento de escolha do m\u00e9dico em participantes com c\u00e2ncer de endom\u00e9trio ap\u00f3s quimioterapia \u00e0 base de platina e imunoterapia &nbsp; Popula\u00e7\u00e3o: Evid\u00eancia documentada de c\u00e2ncer endometrial recidivante\/persistente (carcinoma endometrial ou carcinossarcoma); At\u00e9 3 linhas anteriores de terapia sist\u00eamica para c\u00e2ncer endometrial, incluindo quimioterapia sist\u00eamica \u00e0 base de platina e terapia [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/\" \/>\n<meta property=\"og:site_name\" content=\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\\\/\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\\\/\",\"name\":\"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\\\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\"},\"datePublished\":\"2025-08-25T23:19:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensaios Cl\u00ednicos\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\\\/persistente\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/\",\"name\":\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ptbr.idor.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","canonical":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/","og_locale":"pt_BR","og_type":"article","og_title":"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","og_description":"Estudo de Sacituzumabe Govitecana versus tratamento de escolha do m\u00e9dico em participantes com c\u00e2ncer de endom\u00e9trio ap\u00f3s quimioterapia \u00e0 base de platina e imunoterapia &nbsp; Popula\u00e7\u00e3o: Evid\u00eancia documentada de c\u00e2ncer endometrial recidivante\/persistente (carcinoma endometrial ou carcinossarcoma); At\u00e9 3 linhas anteriores de terapia sist\u00eamica para c\u00e2ncer endometrial, incluindo quimioterapia sist\u00eamica \u00e0 base de platina e terapia [&hellip;]","og_url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/","og_site_name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/","url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/","name":"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","isPartOf":{"@id":"https:\/\/ptbr.idor.org\/#website"},"datePublished":"2025-08-25T23:19:32+00:00","breadcrumb":{"@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/ascent-gyn-01-cancer-de-endometrio-recidivante-persistente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ptbr.idor.org\/"},{"@type":"ListItem","position":2,"name":"Ensaios Cl\u00ednicos","item":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/"},{"@type":"ListItem","position":3,"name":"ASCENT-GYN-01 \u2013 C\u00e2ncer de endom\u00e9trio recidivante\/persistente"}]},{"@type":"WebSite","@id":"https:\/\/ptbr.idor.org\/#website","url":"https:\/\/ptbr.idor.org\/","name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ptbr.idor.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico\/19247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/ensaio_clinico"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=19247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}